Global Health

Beyond Innovation

AMSBIO has progressed since 2000

Greeting Fellowers.

Founded to pursue a healthier life for humans, AMSBIO has continued its research since 2000. We are working hard to create a total solution that considers tools for rapid diagnosis and testing, animals and plants, food and environment as well as the environment.

Based on IVD Device, Rapid Diagnostic Test (RDT), IVD Reagent, and Next Generation Sequencing (NGS), it forms a vast bio-network of countries, national institutions, universities, and hospitals.

The core of AMSBIO is R&D. It is to improve the quality of life for all of us by developing key future IVD technologies through continuous R&D and creating innovative diagnostics and technologies to reflect them in human life.
sign3
R&D

IVD Diagnostic Device

-Extraction Device
-Customized Open Protocol Platform
- Real-Time PCR Device
- Easy to use
- Fully Automatic Integrated molecular diagnostic system
- User Friendly platform
- Minimization of the Hands-on-time

Rapid Diagnostic Test

: Under development
- COVID-19
- Food-Safety (Salmonella, E.coli)
: A+CheQ Rapid Kit
- Pet (Canine/Feline)
- Animal epidemic (Swine/Bovine/Poultry)

IVD Reagent

- COVID-19
Avellino Corneal
Dystrophy (5types)
- Seasonal Influenza
- ASFV
- AI
- FMDV
- Pet

Next Generation Sequencing

- Cancer
- Rumen Microorganism (16s metagenomics)
-Traits & Disorders
-ID & Parentage
-Rumen Microorganism (16s metagenomics)